Log in to your Inderes Free account to see all free content on this page.
Miris Holding
38.49 SEK
-0.54 %
Less than 1K followers
MIR
Spotlight Stock Market
Biotechnology & Pharmaceuticals
Health Care
Overview
Financials & Estimates
Ownership
Dividend
Investor consensus
Valuation
Income statement
Quarter data
Income statement
Financial statements, revenue, EBIT, valuation metrics, and quarterly estimates for Miris Holding
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|
| Revenue | 11.8 | 10.8 | 15.2 | 18.7 | 15.5 | 17.6 | 17.5 |
| growth-% | -8.2 % | 41.3 % | 22.4 % | -17.1 % | 13.5 % | -0.5 % | |
| EBITDA | -18.7 | -9.7 | -9.6 | -7.9 | -10.1 | -4.8 | -4.0 |
| EBIT | -21.9 | -13.1 | -13.0 | -11.3 | -13.1 | -5.3 | -4.0 |
| Profit before taxes | -22.6 | -13.4 | -13.4 | -11.4 | -13.8 | -6.3 | -4.8 |
| Net income | -22.6 | -13.4 | -13.4 | -11.4 | -13.8 | -6.3 | -4.8 |
| EPS | -744.68 | -324.61 | -208.41 | -117.50 | -126.27 | -25.04 | -0.02 |
| Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend ratio | -0.0 % | -0.0 % | -0.0 % | -0.0 % | -0.0 % | -0.0 % | -0.0 % |
Login required
This content is only available for logged in users
Profitability and return on capital
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|
| EBITDA-% | -159.3 % | -90.4 % | -63.0 % | -42.2 % | -65.3 % | -27.1 % | -22.8 % |
| EBIT-% | -186.7 % | -121.7 % | -85.3 % | -60.4 % | -84.9 % | -30.1 % | -22.8 % |
| ROE | -141.8 % | -743.0 % | -79.1 % | -96.8 % | 691.0 % | -231.0 % | -23.9 % |
| ROI | -68.8 % | -67.5 % | -46.7 % | -53.2 % | -66.9 % | -28.2 % | -15.9 % |
Login required
This content is only available for logged in users